Showing results (301-310 of 331) with videos related to
Sort By:
Pageof 34
Internal and Emergency Medicine|February 10, 2021
Clinical features and disease course of patients with acute ischaemic stroke just before the Italian index case: Was COVID-19 already there?Anna M Pietroboni, Silvia Lanfranconi, Alessio Novella, et al.Journal of Alzheimer'S Disease : JAD|May 12, 2011
A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasiaChiara Villa, Laura Ghezzi, Anna M Pietroboni, et al.Journal of Cellular and Molecular Medicine|February 8, 2020
Nusinersen treatment and cerebrospinal fluid neurofilaments: An explorative study on Spinal Muscular Atrophy type 3 patientsIrene Faravelli, Megi Meneri, Domenica Saccomanno, et al.Plos One|April 17, 2012
Progranulin gene variability and plasma levels in bipolar disorder and schizophreniaDaniela Galimberti, Bernardo Dell'Osso, Chiara Fenoglio, et al.Journal of Alzheimer'S Disease : JAD|June 29, 2011
Role of OLR1 and its regulating hsa-miR369-3p in Alzheimer's disease: genetics and expression analysisMaria Serpente, Chiara Fenoglio, Chiara Villa, et al.Journal of Alzheimer'S Disease : JAD|December 16, 2010
BAG1 is a protective factor for sporadic frontotemporal lobar degeneration but not for Alzheimer's diseaseEliana Venturelli, Chiara Villa, Chiara Fenoglio, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 23, 2012
Selective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDIIClaudio D'Addario, Bernardo Dell'Osso, Maria Carlotta Palazzo, et al.Journal of Alzheimer'S Disease : JAD|January 12, 2010
GRN variability contributes to sporadic frontotemporal lobar degenerationDaniela Galimberti, Chiara Fenoglio, Francesca Cortini, et al.Journal of Molecular Neuroscience : MN|April 24, 2016
New Mutations in NEB Gene Discovered by Targeted Next-Generation Sequencing in Nemaline Myopathy Italian PatientsDaniela Piga, Francesca Magri, Dario Ronchi, et al.Cellular and Molecular Life Sciences : CMLS|November 25, 2023
Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot-Marie-Tooth type 2AFederica Rizzo, Silvia Bono, Marc David Ruepp, et al.Pageof 34